The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Endocytosis and Cancer
Open accessAbstract
Endocytosis entails selective packaging of cell-surface proteins, such as receptors for cytokines and adhesion components, in cytoplasmic vesicles (endosomes).The series of sorting events that determines the fate of internalized proteins, either degradation in lysosomes or recycling back to the plasma membrane, relies on intrinsic sequence motifs, posttranslational modifications (e.g., phosphorylation and ubiquitination), and transient assemblies of both Rab GTPases and phosphoinositide-binding proteins.This multicomponent process is enhanced and skewed in cancer cells; we review mechanisms enabling both major drivers of cancer, p53 and Ras, to bias recycling of integrins and receptor tyrosine kinases (RTKs).Likewise, cadherins and other junctional proteins of cancer cells are constantly removed from the cell surface, thereby disrupting tissue polarity and instigating motile phenotypes.Mutant forms of RTKs able to evade Cbl-mediated ubiquitination, along with overexpression of the wild-type forms and a variety of defective feedback regulatory loops, are frequently detected in tumors.Finally, we describe pharmacological attempts to harness the peculiar endocytic system of cancer, in favor of effective patient treatment.C ancer cells are fundamentally similar to their normal counterparts.Their differences lie in a series of relatively subtle modifications of normal physiological processes that, when combined, can create markedly altered phenotypes and behaviors.It has long been suspected that endocytosis is one such physiological process that is modified in cancer.Not only do cancer cells show alterations in the overall appearance and dynamics of the plasma membrane, but also the common inability of cancer cells to properly regulate the function of several types of receptors, including many RTKs, strongly suggests an inability to internalize, recycle, or degrade these key cancer drivers.In recent years, there has been considerable progress made toward under-standing the breadth and mechanisms of alterations to the endocytic pathway that occur during cancer.Although our knowledge remains incomplete and the pathophysiological contributions of these alterations may not be wholly understood, this review considers just how profoundly the pathways of endocytosis can be modified in cancer and what this reveals about disease mechanisms and normal processes. Organization of the Endocytic PathwayAlthough the basic features of the endocytic pathway in animal cells were established more than two decades ago (Mellman 1996a), subsequent years have witnessed the accumulation of
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486 · cited 2×
“Approximately 10% to 30% of tumors from patients with non-small-cell lung cancer (NSCLC) harbor somatic activating mutations in the gene encoding EGFR (Lynch et al. 2004; Paez et al. 2004; Pao et al. 2004).”
BackgroundThe basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Pao, W., Miller, V., Zakowski, M., Doherty, J., Politi, K., Sarkaria, I., Singh, B., Heelan, R., Rusch, V., Fulton, L., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405220101 · Cited by 4,338
Trastuzumab emtansine for HER2-positive advanced breast cancer
Verma, S., Miles, D., Gianni, L., Krop, I. E., Welslau, M., Baselga, J., Pegram, M., Oh, D.-Y., Diéras, V., Guardino, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209124 · Cited by 3,834
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
Baselga, J., Campone, M., Piccart, M., Burris, H. A., Rugo, H. S., Sahmoud, T., Noguchi, S., Gnant, M., Pritchard, K. I., Lebrun, F., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109653 · Cited by 2,863
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Baselga, J., Cortés, J., Kim, S.-B., Im, S.-A., Hegg, R., Im, Y.-H., Roman, L., Pedrini, J. L., Pienkowski, T., Knott, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113216 · Cited by 2,532
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789
Zoncu, R., Bar-Peled, L., Efeyan, A., Wang, S., Sancak, Y., & Sabatini, D. M. (2011) · Science · doi:10.1126/science.1207056 · Cited by 1,673
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
ENDOCYTOSIS AND MOLECULAR SORTING
Mellman, I. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.575 · Cited by 1,533
Self-citationHallmarks of Cancer: The Next Generation
Roizen, M. F. (2012) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/j.yane.2012.02.046 · Cited by 1,501
Katzmann, D. J., Babst, M., & Emr, S. D. (2001) · Cell · doi:10.1016/s0092-8674(01)00434-2 · Cited by 1,429
The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins
Raiborg, C., & Stenmark, H. (2009) · Nature · doi:10.1038/nature07961 · Cited by 1,359
Autocrine Secretion and Malignant Transformation of Cells
Sporn, M. B., & Todaro, G. J. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010093031511 · Cited by 1,346
Endocytosis and signalling: intertwining molecular networks
Sorkin, A., & von Zastrow, M. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2748 · Cited by 1,064
ErbB receptors and signaling pathways in cancer
Hynes, N. E., & MacDonald, G. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.12.010 · Cited by 956
An essential role for free radicals and derived species in signal transduction
Lander, H. M. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.2.9039953 · Cited by 902
Amino acid signalling upstream of mTOR
Jewell, J. L., Russell, R. C., & Guan, K.-L. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3522 · Cited by 894
Control of EGF receptor signaling by clathrin-mediated endocytosis
Vieira, A. V., Lamaze, C., & Schmid, S. L. (1996) · Science · doi:10.1126/science.274.5295.2086 · Cited by 883
c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor
Levkowitz, G., Waterman, H., Zamir, E., Kam, Z., Oved, S., Langdon, W. Y., Beguinot, L., Geiger, B., & Yarden, Y. (1998) · Genes & Development · doi:10.1101/gad.12.23.3663 · Cited by 865
Self-citationWong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., & Vogelstein, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6899 · Cited by 849
Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex
Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H. E. M., Behrens, J., Sommer, T., & Birchmeier, W. (2002) · Nature Cell Biology · doi:10.1038/ncb758 · Cited by 846
Regulation of Receptor Fate by Ubiquitination of Activated β 2 -Adrenergic Receptor and β-Arrestin
Shenoy, S. K., McDonald, P. H., Kohout, T. A., & Lefkowitz, R. J. (2001) · Science · doi:10.1126/science.1063866 · Cited by 824
Mutant p53 drives invasion by promoting integrin recycling
Muller, P. A. J., Caswell, P. T., Doyle, B., Iwanicki, M. P., Tan, E. H., Karim, S., Lukashchuk, N., Gillespie, D. A., Ludwig, R. L., Gosselin, P., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.026 · Cited by 796
EGFR Mutations in Lung Cancer: Correlation With Clinical Response to Gefitinib Therapy
Tanoue, L. T. (2006) · Yearbook of Pulmonary Disease · doi:10.1016/s8756-3452(08)70092-6 · Cited by 776
Pinkas-Kramarski, R., Soussan, L., Waterman, H., Levkowitz, G., Alroy, I., Klapper, L., Lavi, S., Seger, R., Ratzkin, B. J., Sela, M., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00603.x · Cited by 769
Self-citationMutant p53 Gain-of-Function in Cancer
Oren, M., & Rotter, V. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001107 · Cited by 753
Clathrin-independent endocytosis of ubiquitinated cargos
Sigismund, S., Woelk, T., Puri, C., Maspero, E., Tacchetti, C., Transidico, P., Di Fiore, P. P., & Polo, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409817102 · Cited by 739
Induction of Membrane Ruffling and Fluid-Phase Pinocytosis in Quiescent Fibroblasts by ras Proteins
Bar-Sagi, D., & Feramisco, J. R. (1986) · Science · doi:10.1126/science.3090687 · Cited by 734
Derailed endocytosis: an emerging feature of cancer
Mosesson, Y., Mills, G. B., & Yarden, Y. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2521 · Cited by 718
Self-citationTakezawa, K., Pirazzoli, V., Arcila, M. E., Nebhan, C. A., Song, X., de Stanchina, E., Ohashi, K., Janjigian, Y. Y., Spitzler, P. J., Melnick, M. A., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0108 · Cited by 710
Sigismund, S., Argenzio, E., Tosoni, D., Cavallaro, E., Polo, S., & Di Fiore, P. P. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.06.012 · Cited by 679
Microtubule-induced focal adhesion disassembly is mediated by dynamin and focal adhesion kinase
Ezratty, E. J., Partridge, M. A., & Gundersen, G. G. (2005) · Nature Cell Biology · doi:10.1038/ncb1262 · Cited by 650
Cbl: many adaptations to regulate protein tyrosine kinases
Thien, C. B. F., & Langdon, W. Y. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35067100 · Cited by 625
Targeting the PI3K signaling pathway in cancer
Wong, K.-K., Engelman, J. A., & Cantley, L. C. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.002 · Cited by 543
Spatial control of EGF receptor activation by reversible dimerization on living cells
Chung, I., Akita, R., Vandlen, R., Toomre, D., Schlessinger, J., & Mellman, I. (2010) · Nature · doi:10.1038/nature08827 · Cited by 538
Self-citationClathrin-independent pathways of endocytosis
Mayor, S., Parton, R. G., & Donaldson, J. G. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016758 · Cited by 525
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers
Cheng, K. W., Lahad, J. P., Kuo, W.-L., Lapuk, A., Yamada, K., Auersperg, N., Liu, J., Smith-McCune, K., Lu, K. H., Fishman, D., et al. (2004) · Nature Medicine · doi:10.1038/nm1125 · Cited by 509
Austin, C. D., De Mazière, A. M., Pisacane, P. I., van Dijk, S. M., Eigenbrot, C., Sliwkowski, M. X., Klumperman, J., & Scheller, R. H. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-07-0591 · Cited by 496
Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis
Pece, S., Serresi, M., Santolini, E., Capra, M., Hulleman, E., Galimberti, V., Zurrida, S., Maisonneuve, P., Viale, G., & Di Fiore, P. P. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200406140 · Cited by 483
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39104c1 · Cited by 465
Integrins: masters and slaves of endocytic transport
Caswell, P. T., Vadrevu, S., & Norman, J. C. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2799 · Cited by 460
All ErbB Receptors Other Than the Epidermal Growth Factor Receptor Are Endocytosis Impaired
Baulida, J., Kraus, M. H., Alimandi, M., Fiore, P. P. D., & Carpenter, G. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.5251 · Cited by 454
Developmental Control of Endocytosis in Dendritic Cells by Cdc42
Garrett, W. S., Chen, L.-M., Kroschewski, R., Ebersold, M., Turley, S., Trombetta, S., Galán, J. E., & Mellman, I. (2000) · Cell · doi:10.1016/s0092-8674(00)00038-6 · Cited by 452
Self-citationEndocytic Trafficking of Rac Is Required for the Spatial Restriction of Signaling in Cell Migration
Palamidessi, A., Frittoli, E., Garré, M., Faretta, M., Mione, M., Testa, I., Diaspro, A., Lanzetti, L., Scita, G., & Di Fiore, P. P. (2008) · Cell · doi:10.1016/j.cell.2008.05.034 · Cited by 452
Imaging Sites of Receptor Dephosphorylation by PTP1B on the Surface of the Endoplasmic Reticulum
Haj, F. G., Verveer, P. J., Squire, A., Neel, B. G., & Bastiaens, P. I. H. (2002) · Science · doi:10.1126/science.1067566 · Cited by 434
Lenferink, A. E. G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3385 · Cited by 413
Nagane, M., Coufal, F. J., Lin, H., Bögler, O., Cavenee, W. K., & Huang, H.-J. S. (1996) · PubMed · Cited by 405
Neckers, L., & Ivy, S. P. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200311000-00003 · Cited by 400
Rab11 in Recycling Endosomes Regulates the Sorting and Basolateral Transport of E-Cadherin
Lock, J. G., & Stow, J. L. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-10-0867 · Cited by 389
Caswell, P. T., Chan, M., Lindsay, A. J., McCaffrey, M. W., Boettiger, D., & Norman, J. C. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200804140 · Cited by 388
Rab25 Associates with α5β1 Integrin to Promote Invasive Migration in 3D Microenvironments
Caswell, P. T., Spence, H. J., Parsons, M., White, D. P., Clark, K., Cheng, K. W., Mills, G. B., Humphries, M. J., Messent, A. J., Anderson, K. I., et al. (2007) · Developmental Cell · doi:10.1016/j.devcel.2007.08.012 · Cited by 387
Teis, D., Wunderlich, W., & Huber, L. A. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00364-7 · Cited by 371
Muthuswamy, S. K., Gilman, M., & Brugge, J. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6845 · Cited by 363
Fusion of the ALK Gene to the Clathrin Heavy Chain Gene, CLTC, in Inflammatory Myofibroblastic Tumor
Bridge, J. A., Kanamori, M., Ma, Z., Pickering, D., Hill, D. A., Lydiatt, W., Lui, M. Y., Colleoni, G. W. B., Antonescu, C. R., Ladanyi, M., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61711-7 · Cited by 359
Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface
Zhang, X., Pickin, K. A., Bose, R., Jura, N., Cole, P. A., & Kuriyan, J. (2007) · Nature · doi:10.1038/nature05998 · Cited by 357
Di Guglielmo, G. M., Baass, P. C., Ou, W. J., Posner, B. I., & Bergeron, J. J. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06747.x · Cited by 355
Roberts, M., Barry, S., Woods, A., van der Sluijs, P., & Norman, J. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00442-0 · Cited by 348
Palacios, F., Tushir, J. S., Fujita, Y., & D'Souza-Schorey, C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.389-402.2005 · Cited by 333
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas
Di Renzo, M. F., Olivero, M., Martone, T., Maffe, A., Maggiora, P., De Stefani, A., Valente, G., Giordano, S., Cortesina, G., & Comoglio, P. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203455 · Cited by 332
Li, L., & Cohen, S. N. (1996) · Cell · doi:10.1016/s0092-8674(00)81111-3 · Cited by 331
Worthylake, R., Opresko, L. K., & Wiley, H. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8865 · Cited by 325
Dozynkiewicz, M. A., Jamieson, N. B., MacPherson, I., Grindlay, J., van den Berghe, P. V. E., von Thun, A., Morton, J. P., Gourley, C., Timpson, P., Nixon, C., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2011.11.008 · Cited by 325
Ras‐activated endocytosis is mediated by the Rab5 guanine nucleotide exchange activity of RIN1
Tall, G. G., Barbieri, M. A., Stahl, P. D., & Horazdovsky, B. F. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00008-9 · Cited by 308
The Drg-1 gene suppresses tumor metastasis in prostate cancer.
Bandyopadhyay, S., Pai, S. K., Gross, S. C., Hirota, S., Hosobe, S., Miura, K., Saito, K., Commes, T., Hayashi, S., Watabe, M., et al. (2003) · PubMed · Cited by 308
Palacios, F., Schweitzer, J. K., Boshans, R. L., & D'Souza-Schorey, C. (2002) · Nature Cell Biology · doi:10.1038/ncb881 · Cited by 303
Caveolin-1 in tumor progression: the good, the bad and the ugly
Goetz, J. G., Lajoie, P., Wiseman, S. M., & Nabi, I. R. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9160-9 · Cited by 299
Wang, Y., Pennock, S., Chen, X., & Wang, Z. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7279-7290.2002 · Cited by 295
LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation
Gur, G., Rubin, C., Katz, M., Amit, I., Citri, A., Nilsson, J., Amariglio, N., Henriksson, R., Rechavi, G., Hedman, H., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600342 · Cited by 291
Self-citationTargeting the Hepatocyte Growth Factor–cMET Axis in Cancer Therapy
Blumenschein, G. R., Mills, G. B., & Gonzalez-Angulo, A. M. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.3774 · Cited by 273
Ruivenkamp, C. A. L., van Wezel, T., Zanon, C., Stassen, A. P. M., Vlcek, C., Csikós, T., Klous, A. M., Tripodis, N., Perrakis, A., Boerrigter, L., et al. (2002) · Nature Genetics · doi:10.1038/ng903 · Cited by 259
Goh, L. K., Huang, F., Kim, W., Gygi, S., & Sorkin, A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201001008 · Cited by 258
Friedman, L. M., Rinon, A., Schechter, B., Lyass, L., Lavi, S., Bacus, S. S., Sela, M., & Yarden, Y. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409610102 · Cited by 252
Self-citationFranovic, A., Gunaratnam, L., Smith, K., Robert, I., Patten, D., & Lee, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702387104 · Cited by 250
Aranda, V., Haire, T., Nolan, M. E., Calarco, J. P., Rosenberg, A. Z., Fawcett, J. P., Pawson, T., & Muthuswamy, S. K. (2006) · Nature Cell Biology · doi:10.1038/ncb1485 · Cited by 243
Laederich, M. B., Funes-Duran, M., Yen, L., Ingalla, E., Wu, X., Carraway, K. L., & Sweeney, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409703200 · Cited by 239
A direct role for Met endocytosis in tumorigenesis
Joffre, C., Barrow, R., Ménard, L., Calleja, V., Hart, I. R., & Kermorgant, S. (2011) · Nature Cell Biology · doi:10.1038/ncb2257 · Cited by 238
Hsu, J.-M., Chen, C.-T., Chou, C.-K., Kuo, H.-P., Li, L.-Y., Lin, C.-Y., Lee, H.-J., Wang, Y.-N., Liu, M., Liao, H.-W., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2158 · Cited by 236
Citri, A. (2002) · The EMBO Journal · doi:10.1093/emboj/21.10.2407 · Cited by 233
Wiley, H. S. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.2.801 · Cited by 230
Epithelial E- and P-cadherins: Role and clinical significance in cancer
Paredes, J., Figueiredo, J., Albergaria, A., Oliveira, P., Carvalho, J., Ribeiro, A. S., Caldeira, J., Costa, Â. M., Simões-Correia, J., Oliveira, M. J., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.05.002 · Cited by 229
Morishige, M., Hashimoto, S., Ogawa, E., Toda, Y., Kotani, H., Hirose, M., Wei, S., Hashimoto, A., Yamada, A., Yano, H., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1672 · Cited by 220
FMS mutations in myelodysplastic, leukemic, and normal subjects.
Ridge, S. A., Worwood, M., Oscier, D., Jacobs, A., & Padua, R. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1377 · Cited by 220
Pedersen, M. W., Jacobsen, H. J., Koefoed, K., Hey, A., Pyke, C., Haurum, J. S., & Kragh, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1417 · Cited by 219
The role of EGF-related peptides in tumor growth
Normanno, N. (2001) · Frontiers in Bioscience · doi:10.2741/a635 · Cited by 216
Flt3-dependent transformation by inactivating c-Cbl mutations in AML
Sargin, B., Choudhary, C., Crosetto, N., Schmidt, M. H. H., Grundler, R., Rensinghoff, M., Thiessen, C., Tickenbrock, L., Schwäble, J., Brandts, C., et al. (2007) · Blood · doi:10.1182/blood-2007-01-066076 · Cited by 213
Clathrin is a key regulator of basolateral polarity
Deborde, S., Perret, E., Gravotta, D., Deora, A., Salvarezza, S., Schreiner, R., & Rodriguez-Boulan, E. (2008) · Nature · doi:10.1038/nature06828 · Cited by 213
Ubiquitin-Dependent Sorting in Endocytosis
Piper, R. C., Dikic, I., & Lukacs, G. L. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016808 · Cited by 208
Ghiglione, C., Carraway, K. L., Amundadottir, L. T., Boswell, R. E., Perrimon, N., & Duffy, J. B. (1999) · Cell · doi:10.1016/s0092-8674(00)80594-2 · Cited by 208
Abella, J. V., Peschard, P., Naujokas, M. A., Lin, T., Saucier, C., Urbé, S., & Park, M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9632-9645.2005 · Cited by 203
Diversity of Clathrin Function: New Tricks for an Old Protein
Brodsky, F. M. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101011-155716 · Cited by 201
p120-catenin binding masks an endocytic signal conserved in classical cadherins
Nanes, B. A., Chiasson-MacKenzie, C., Lowery, A. M., Ishiyama, N., Faundez, V., Ikura, M., Vincent, P. A., & Kowalczyk, A. P. (2012) · Journal of Cell Biology · doi:10.1083/jcb.201205029 · Cited by 197
Regulation of endocytosis via the oxygen-sensing pathway
Wang, Y., Roche, O., Yan, M. S., Finak, G., Evans, A. J., Metcalf, J. L., Hast, B. E., Hanna, S. C., Wondergem, B., Furge, K. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1922 · Cited by 192
Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion
Muller, P. A. J., Trinidad, A. G., Timpson, P., Morton, J. P., Zanivan, S., van den Berghe, P. V. E., Nixon, C., Karim, S. A., Caswell, P. T., Noll, J. E., et al. (2013) · Oncogene · doi:10.1038/onc.2012.148 · Cited by 192
Cdc42 localization and cell polarity depend on membrane traffic
Osmani, N., Peglion, F., Chavrier, P., & Etienne-Manneville, S. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003091 · Cited by 190
Gamou, S., & Shimizu, N. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01335-x · Cited by 188
PKD1/PKCμ promotes αvβ3 integrin recycling and delivery to nascent focal adhesions
Woods, A. J., White, D. P., Caswell, P. T., & Norman, J. C. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600267 · Cited by 182
Ubiquitination of K-Ras Enhances Activation and Facilitates Binding to Select Downstream Effectors
Sasaki, A. T., Carracedo, A., Locasale, J. W., Anastasiou, D., Takeuchi, K., Kahoud, E. R., Haviv, S., Asara, J. M., Pandolfi, P. P., & Cantley, L. C. (2011) · Science Signaling · doi:10.1126/scisignal.2001518 · Cited by 182
Long-distance retrograde neurotrophic signaling
Howe, C. L., & Mobley, W. C. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.01.010 · Cited by 179
Ben-Kasus, T., Schechter, B., Lavi, S., Yarden, Y., & Sela, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812059106 · Cited by 172
Self-citationBlagosklonny, M. V. (2000) · The FASEB Journal · doi:10.1096/fj.99-1078rev · Cited by 170
Li, J., Ballif, B. A., Powelka, A. M., Dai, J., Gygi, S. P., & Hsu, V. W. (2005) · Developmental Cell · doi:10.1016/j.devcel.2005.09.012 · Cited by 161
Acidic Environment Leads to ROS-Induced MAPK Signaling in Cancer Cells
Riemann, A., Schneider, B., Ihling, A., Nowak, M., Sauvant, C., Thews, O., & Gekle, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022445 · Cited by 160
Spiridon, C., Ghetie, M.-A., Uhr, J. W., Marcheş, R., Li, J. L., Shen, G. L., & Vitetta, E. S. (2002) · PubMed · Cited by 157
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling
Shtiegman, K., Kochupurakkal, B. S., Zwang, Y., Pines, G., Starr, A., Vexler, A. M., Citri, A., Katz, M., Lavi, S., Ben-Basat, Y., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210503 · Cited by 155
Self-citationSpangler, J. B., Neil, J. R., Abramovitch, S., Yarden, Y., White, F. M., Lauffenburger, D. A., & Wittrup, K. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913476107 · Cited by 154
Self-citationCoupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins.
Levkowitz, G., Klapper, L. N., Tzahar, E., Freywald, A., Sela, M., & Yarden, Y. (1996) · PubMed · Cited by 154
Self-citationEGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes
Grandal, M. V., Zandi, R., Pedersen, M. W., Willumsen, B. M., van Deurs, B., & Poulsen, H. S. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm058 · Cited by 151
Parachoniak, C. A., Luo, Y., Abella, J. V., Keen, J. H., & Park, M. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.05.007 · Cited by 150
Oriented endocytic recycling of α5β1 in motile neutrophils
Pierini, L. M., Lawson, M. A., Eddy, R. J., Hendey, B., & Maxfield, F. R. (2000) · Blood · doi:10.1182/blood.v95.8.2471 · Cited by 149
French, A. R., Sudlow, G., Wiley, H. S., & Lauffenburger, D. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40744-7 · Cited by 147
Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1
van der Horst, E. H., Degenhardt, Y., Strelow, A., Slavin, A., Chinn, L., Orf, J. N., Rong, M., Li, S., See, L.-H., Nguyen, K. C. Q., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508014102 · Cited by 145
Ramsay, A. G., Epple, M., Jazayeri, M., Thomas, G. J., Parsons, M., Violette, S. M., Weinreb, P. H., Hart, I. R., & Marshall, J. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0318 · Cited by 140
Letessier, A., Sircoulomb, F., Ginestier, C., Cervera, N., Monville, F., Gelsi‐Boyer, V., Esterni, B., Geneix, J., Finetti, P., Zemmour, C., et al. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-245 · Cited by 139
Hsp90 restrains ErbB‐2/HER2 signalling by limiting heterodimer formation
Citri, A., Gan, J., Mosesson, Y., Vereb, G., Szöllõsi, J., & Yarden, Y. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400300 · Cited by 139
Self-citationH-Ras Signaling and K-Ras Signaling Are Differentially Dependent on Endocytosis
Roy, S., Wyse, B. D., & Hancock, J. F. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.14.5128-5140.2002 · Cited by 139
Bao, J., Gur, G., & Yarden, Y. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437945100 · Cited by 138
Self-citationHe, H., Dai, F., Yu, L., She, X., Zhao, Y. B., Jiang, J., Chen, X., & Zhao, S. (2002) · Gene Expression · doi:10.3727/000000002783992406 · Cited by 132
An ACAP1-containing clathrin coat complex for endocytic recycling
Li, J., Peters, P. J., Bai, M., Dai, J., Bos, E., Kirchhausen, T. L., Kandror, K. V., & Hsu, V. W. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200608033 · Cited by 132
Mig-6 controls EGFR trafficking and suppresses gliomagenesis
Ying, H., Zheng, H., Scott, K. L., Wiedemeyer, R., Yan, H., Lim, C., Huang, J. S., Dhakal, S., Ivanova, E. V., Xiao, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914930107 · Cited by 131
Cbl and Human Myeloid Neoplasms: The Cbl Oncogene Comes of Age
Kales, S. C., Ryan, P. E., Nau, M. M., & Lipkowitz, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0610 · Cited by 130
A clathrin-dependent pathway leads to KRas signaling on late endosomes en route to lysosomes
Lu, A., Tebar, F., Alvarez-Moya, B., López-Alcalá, C., Calvo, M., Enrich, C., Agell, N., Nakamura, T., Matsuda, M., & Bachs, O. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200807186 · Cited by 129
Frosi, Y., Anastasi, S., Ballarò, C., Varsano, G., Castellani, L., Maspero, E., Polo, S., Alemà, S., & Segatto, O. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201002032 · Cited by 125
Feedback inhibition by RALT controls signal output by the ErbB network
Anastasi, S., Fiorentino, L., Fiorini, M., Fraioli, R., Sala, G., Castellani, L., Alemà, S., Alimandi, M., & Segatto, O. (2003) · Oncogene · doi:10.1038/sj.onc.1206516 · Cited by 122
An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR Endocytosis
Tarcic, G., Boguslavsky, S., Wakim, J., Kiuchi, T., Liu, A. H.-C., Reinitz, F., Nathanson, D., Takahashi, T., Mischel, P. S., Ng, T., et al. (2009) · Current Biology · doi:10.1016/j.cub.2009.09.048 · Cited by 122
Self-citationRCP is a human breast cancer–promoting gene with Ras-activating function
Zhang, J., Liu, X., Datta, A., Govindarajan, K. R., Tam, W. L., Han, J., George, J., Wong, C. K., Ramnarayanan, K., Phua, T. Y., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37622 · Cited by 121
Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network
Tzahar, E., Moyer, J. D., Waterman, H., Barbacci, E. G., Bao, J., Levkowitz, G., Shelly, M., Strano, S., Pinkas‐Kramarski, R., Pierce, J. H., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.20.5948 · Cited by 121
Self-citationInhibition of triple-negative breast cancer models by combinations of antibodies to EGFR
Ferraro, D. A., Gaborit, N., Maron, R., Cohen‐Dvashi, H., Porat, Z., Pareja, F. G., Lavi, S., Lindzen, M., Ben‐Chetrit, N., Sela, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220763110 · Cited by 118
Self-citationSo, C. W. E., Caldas, C., Liu, M.-M., Chen, S., Huang, Q., Gu, L.-J., Sham, M. H., Wiedemann, L. M., & Chan, L. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2563 · Cited by 117
Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells
Rao, D. S., Bradley, S. V., Kumar, P. D., Hyun, T. S., Saint‐Dic, D., Oravecz-Wilson, K. I., Kleer, C. G., & Ross, T. S. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00107-7 · Cited by 117
Feedback Regulation of Ras Signaling by Rabex-5-Mediated Ubiquitination
Xu, L., Lubkov, V., Taylor, L. J., & Bar‐Sagi, D. (2010) · Current Biology · doi:10.1016/j.cub.2010.06.051 · Cited by 114
Quantitative proteomics identifies a Dab2/integrin module regulating cell migration
Teckchandani, A., Toida, N., Goodchild, J., Henderson, C., Watts, J., Wollscheid, B., & Cooper, J. A. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200812160 · Cited by 110
The c‐Cbl/CD2AP complex regulates VEGF‐induced endocytosis and degradation of Flt‐1 (VEGFR‐1)
Kobayashi, S., Sakaue-Sawano, A., Nojima, Y., Shibuya, M., & Maru, Y. (2004) · The FASEB Journal · doi:10.1096/fj.03-0767fje · Cited by 97
LRIG inhibitors of growth factor signalling – double-edged swords in human cancer?
Hedman, H., & Henriksson, R. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2006.10.021 · Cited by 96
Tanemura, A., Nagasawa, T., Inui, S., & Itami, S. (2006) · Dermatologic Surgery · doi:10.1111/j.1524-4725.2005.31108 · Cited by 92
Hannigan, A., Smith, P., Kalna, G., Lo Nigro, C., Orange, C., O’Brien, D. I., Shah, R., Syed, N., Spender, L. C., Herrera, B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36125 · Cited by 92
Koefoed, K., Steinaa, L., Søderberg, J. N., Kjær, I., Jacobsen, H. J., Meijer, P., Haurum, J. S., Jensen, A. D., Kragh, M., Andersen, P. S., et al. (2011) · mAbs · doi:10.4161/mabs.3.6.17955 · Cited by 91
Systems Biology of Growth Factor‐Induced Receptor Endocytosis
Zwang, Y., & Yarden, Y. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00870.x · Cited by 87
Self-citationTyrosine phosphorylated Par3 regulates epithelial tight junction assembly promoted by EGFR signaling
Wang, Y., Du, D., Fang, L., Yang, G., Zhang, C., Zeng, R., Ullrich, A., Lottspeich, F., & Chen, Z. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601384 · Cited by 83
Jeuken, J. W. M., Sijben, A. E. J., Alenda, C., Rijntjes, J., Dekkers, M. M. G., Boots‐Sprenger, S., McLendon, R. E., & Wesseling, P. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00320.x · Cited by 79
Hypophosphorylation of residue Y1045 leads to defective downregulation of EGFRvIII
Han, W., Zhang, T., Yu, H. W., Foulke, J. G., & Tang, C. K. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.10.3226 · Cited by 77
Filosto, S., Khan, E. M., Tognon, E., Becker, C. R., Ashfaq, M., Ravid, T., & Goldkorn, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023240 · Cited by 72
EGFRvIV: a previously uncharacterized oncogenic mutant reveals a kinase autoinhibitory mechanism
Pines, G., Huang, P. H., Zwang, Y., White, F. M., & Yarden, Y. (2010) · Oncogene · doi:10.1038/onc.2010.313 · Cited by 71
Self-citationInteraction of Hsp90 with the Nascent Form of the Mutant Epidermal Growth Factor Receptor EGFRvIII
Lavictoire, S. J., Parolin, D. A. E., Klimowicz, A., Kelly, J. F., & Lorimer, I. A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209494200 · Cited by 67
Balaji, K., Mooser, C. K., Janson, C., Bliss, J. M., Hojjat, H., & Colicelli, J. (2012) · Journal of Cell Science · doi:10.1242/jcs.113688 · Cited by 67
Krig, S. R., Frietze, S. E., Simion, C., Miller, J. K., Fry, W. H. D., Rafidi, H., Kotelawala, L., Qi, L., Griffith, O. L., Gray, J. W., et al. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0227 · Cited by 67
Christoforides, C., Rainero, E., Brown, K., Norman, J. C., & Toker, A. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.08.008 · Cited by 65
Eppinga, R., Krueger, E. W., Weller, S. G., Zhang, L., Cao, H., & McNiven, M. A. (2011) · Oncogene · doi:10.1038/onc.2011.329 · Cited by 65
Mellman, I. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80026-3 · Cited by 63
Self-citationDynamics of receptor trafficking in tumorigenicity
Parachoniak, C. A., & Park, M. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.02.002 · Cited by 60
Chua, B. T., Lim, S. J., Tham, S. C., Poh, W., & Ullrich, A. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.03.001 · Cited by 60
Cancer therapeutic antibodies come of age: Targeting minimal residual disease
Ben-Kasus, T., Schechter, B., Sela, M., & Yarden, Y. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.01.003 · Cited by 59
Self-citationMak, H., Peschard, P., Lin, T., Naujokas, M. A., Zuo, D., & Park, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210522 · Cited by 57
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Hanna, N. H. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70398-5 · Cited by 56
Decreased DOC-2/DAB2 Expression in Urothelial Carcinoma of the Bladder
Karam, J. A., Shariat, S. F., Huang, H.-Y., Pong, R.-C., Ashfaq, R., Shapiro, E., Lotan, Y., Sagalowsky, A. I., Wu, X., & Hsieh, J. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0287 · Cited by 52
Androgen-related expression of G-proteins in ovarian cancer
Sheach, L. A., Adeney, E. M., Kucukmetin, A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605153 · Cited by 51
Caveolin‐1 is a novel regulator of K‐RAS ‐dependent migration in colon carcinogenesis
Roy, U. K. B., Henkhaus, R. S., Loupakis, F., Cremolini, C., Gerner, E. W., & Ignatenko, N. A. (2012) · International Journal of Cancer · doi:10.1002/ijc.28001 · Cited by 50
Menju, T., Hashimoto, S., Hashimoto, A., Otsuka, Y., Handa, H., Ogawa, E., Toda, Y., Wada, H., Date, H., & Sabe, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025301 · Cited by 44
Genomic amplicons target vesicle recycling in breast cancer
Mills, G. B., Jurišica, I., Yarden, Y., & Norma, J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40256 · Cited by 41
Self-citationRogaia, D., Grignani, F., Carbone, R., Riganelli, D., Lo‐Coco, F., Nakamura, T., Croce, C. M., Fiore, P. P. D., & Pelicci, P. G. (1997) · PubMed · Cited by 39
Increased expression of Rab25 in breast cancer correlates with lymphatic metastasis
Yin, Y., Shen, F., Pei, H., Ding, Y.-B., Zhao, H., Zhao, M., & Chen, Q. (2012) · Tumor Biology · doi:10.1007/s13277-012-0412-5 · Cited by 38
Tomshine, J. C., Severson, S. R., Wigle, D. A., Sun, Z., Beleford, D. T., Shridhar, V., & Horazdovsky, B. F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033514 · Cited by 38
Ubiquitination: Added complexity in Ras and Rho family GTPase function
de la Vega, M., Burrows, J. F., & Johnston, J. A. (2011) · Small GTPases · doi:10.4161/sgtp.2.4.16707 · Cited by 34
Cai, J.-H., Zhao, R., Zhu, J., Jin, X.-L., Wan, F.-J., Liu, K., Ji, X., Zhu, Y., & Zhu, Z. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1247-2 · Cited by 30
Prognostic significance of RIN1 gene expression in human non-small cell lung cancer
Wang, Q., Gao, Y., Tang, Y.-F., Ma, L., Zhao, M., & Wang, X. (2011) · Acta Histochemica · doi:10.1016/j.acthis.2011.08.008 · Cited by 18
Fang, P., Zhao, Z., Tian, H., & Zhang, X. (2012) · Tumor Biology · doi:10.1007/s13277-012-0402-7 · Cited by 14
Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma
Brusegard, K., Stavnes, H. T., Nymoen, D. A., Flatmark, K., Trope, C. G., & Davidson, B. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1191-x · Cited by 13
Cited by
Emerging functions of the EGFR in cancer
Sigismund, S., Avanzato, D., & Lanzetti, L. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12155 · Cited by 1,469
Endocytosis: a pivotal pathway for regulating metastasis
Khan, I., & Steeg, P. S. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01179-8 · Cited by 178
Endosomal trafficking in metabolic homeostasis and diseases
Gilleron, J., & Zeigerer, A. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00737-9 · Cited by 57
Fariha, F. T. J., Fuad, M., Saha, C. S., Hossen, S., & Hossain, M. J. (2025) · Scientific Reports · doi:10.1038/s41598-025-13315-6 · Cited by 1
Metadata
- Authors
- Mellman, I., & Yarden, Y.
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2013-12-01
- Volume
- 5
- Issue
- 12
- Pages
- a016949-a016949
- ISSN
- 1943-0264 (ISSN-L)
- OpenAlex
- W2068322045
- Cited by
- 394
- References
- 171
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.